Aegis Capital Starts Nektar Therapeutics (NKTR) at Buy

November 8, 2016 8:47 AM EST
Get Alerts NKTR Hot Sheet
Price: $12.36 -3.36%

Rating Summary:
    10 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 31 | New: 25
Trade NKTR Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Aegis Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $12.80 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Add Your Comment